EKB Journal Management System
1.

Probiotics versus Rifaximin as Adjuvant Therapy for Helicobacter pylori Eradication

Articles in Press, Accepted Manuscript , Available Online from 21 September 2025
Bahaa Osman Taha; Mohammed Ezz-Eldin; Tarek Abdelrahman
2.

Cognitive Dysfunction in Children with Chronic Liver Diseases and Portal Vein Thrombosis

Volume 92, Issue 06, June 2024, Pages 549-557
MOHAMED G. HENIDY, M.Sc.*** and OLA A. FOUAD, M.D.* MOHAMMED A.E. EL-GUINDI, M.D.*; MAGDY A. SABER, M.D.*; NAHLA M.S. ABDELHADY, M.D.**;
3.

Ameliorative effect of L-carnitine Vs L-carnitine with Rifaximin on skeletal muscle changes in experimentally induced liver cirrhosis in adult male albino rats (biochemical and histological study).

Volume 30, Issue 1, January and February 2024, Pages 279-296
Bassant T. Abd Elbaki; Ghada A. Elsammak; Eman Khaled Soliman; Basma Said Elsayed; Samar Abdelaziz Mostafa
4.

SPONTANEOUS BACTERIAL PERITONITIS PROFILE IN DECOMPENSATED CIRRHOTIC EGYPTIAN PATIENTS

Volume 53, Issue 1, April 2023, Pages 51-56
SAMAR ATEF SEBAWEH; HASSAN S. HAMDY; AMIRA AL BALAKOSY; HEND MUBARAK; MOHAMMED SOBHI HASSAN; LINA ESSAM KHEDR
5.

Effect of rifaximin in the prevention of acute kidney injury and hepatorenal syndrome type II in Egyptian cirrhotic patients

Volume 27, Issue 3, May 2021, Pages 560-566
Ahmed M. El-Gebaly; Nermin S. Ghanem; Ahmed A. Abdelmoaty
6.

EVALUATION OF RIFAXIMIN IN MANAGEMENT OF HEPATIC ENCEPHALOPATHY

Volume 44, Issue 3, December 2014, Pages 677-685
ALI A. WAHIB; M. NEGM EL-DEEN SALEM; MOSTAFA A. AHMED; YASSER M. M. EL-DESSOUKY; DIAA M. EL-TIBY; KHALED EL-MOLA; ABEER M. EL-SAYED